Astrana Health (NASDAQ:ASTH) Stock Price Expected to Rise, Robert W. Baird Analyst Says

Astrana Health (NASDAQ:ASTH) had its price target boosted by Robert W. Baird from $37.00 to $40.00 in a research report issued on Wednesday, MarketBeat Ratings reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s target price would suggest a potential upside of 30.72% from the stock’s previous close.

Other equities analysts have also recently issued reports about the company. Zacks Research upgraded Astrana Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 11th. Truist Financial raised their target price on Astrana Health from $37.00 to $38.00 and gave the company a “buy” rating in a report on Friday, March 13th. Weiss Ratings restated a “sell (d+)” rating on shares of Astrana Health in a report on Monday, December 29th. Finally, BTIG Research decreased their price objective on Astrana Health from $45.00 to $40.00 and set a “buy” rating for the company in a research note on Monday, February 2nd. Six investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Astrana Health currently has an average rating of “Moderate Buy” and an average price target of $34.86.

Astrana Health Stock Performance

Shares of Astrana Health stock opened at $30.60 on Wednesday. The business has a 50-day moving average of $23.60 and a 200 day moving average of $25.34. Astrana Health has a 12 month low of $18.08 and a 12 month high of $34.80. The stock has a market capitalization of $1.70 billion, a price-to-earnings ratio of 66.52 and a beta of 0.77. The company has a debt-to-equity ratio of 1.25, a current ratio of 1.40 and a quick ratio of 1.40.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Monday, March 2nd. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.39. Astrana Health had a return on equity of 5.59% and a net margin of 0.71%.The company had revenue of $950.53 million during the quarter, compared to analysts’ expectations of $930.46 million. During the same period last year, the business posted ($0.15) EPS. Astrana Health’s revenue for the quarter was up 42.9% on a year-over-year basis. As a group, sell-side analysts forecast that Astrana Health will post 1.15 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Royal Bank of Canada raised its stake in Astrana Health by 6.5% during the 1st quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock worth $8,640,000 after acquiring an additional 17,028 shares in the last quarter. AQR Capital Management LLC acquired a new stake in Astrana Health during the 1st quarter worth $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Astrana Health by 5.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock worth $799,000 after acquiring an additional 1,263 shares in the last quarter. Jones Financial Companies Lllp raised its stake in Astrana Health by 4,365.2% during the 1st quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock worth $346,000 after acquiring an additional 10,913 shares in the last quarter. Finally, Intech Investment Management LLC raised its stake in Astrana Health by 5.8% during the 1st quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock worth $1,383,000 after acquiring an additional 2,462 shares in the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.